Programme
Chairpersons:
- Martin Traber, MD, SGPM President and Global Medical Director Roche
- PD Dr Ghazaleh Gouya Lechner, GPMed Board Member and Managing Director Gouya Insights
14:00-14:05 Introduction from the Chairs
14:05-14:25 Corona Immunitas – The National Research Program of the Swiss School of Public Health
Prof Dr Milo Puhan, Director of the Epidemiology, Biostatistics and Prevention Institute, University of Zurich, Switzerland
14:25-14:45 Public Private Partnerships in Times of COVID-19. The Austrian Story
PD Dr Johannes Pleiner-Duxneuner, President GPMed and Medical Director Roche Austria
14:45-14:55 Introduction to DGPharMed and Brief Overview of the COVID-19 Pandemic in Germany
Simone Breitkopf, MD PhD, Medical Consulting, DGPharMed Board Member
14:55-15:05 Evidence Generation for Treatment Recommendations during the COVID-19 Pandemic
Friedhelm Leverkus, Director Health Technology Assessment & Outcomes Research, Pfizer and Member of the DGPharMed WG on Market Access
15:05-15:25 Panel Discussion
15:25-15:30 Conclusions
Dr Marco Romano, MD GFMD IFAPP President
Learning Outcomes
Participants to this webinar will:
- Understand the activities of the Swiss School of Public Health regarding Corona Immunitas;
- Appreciate the interesting public-private partnership activated in Austria;
- Get information about the evolution of the pandemic in Germany and the treatment recommendations generated from several clinical trials.